Powering the Immune System to Transform Lives
Vir Biotechnology is a clinical-stage immunology company leveraging the immune system to develop treatments for infectious diseases and cancer. Its pipeline is built on two core platforms: a next-generation antibody platform and the PRO-XTEN protease-releasable masking technology. Lead programs target chronic hepatitis delta, oncology, HIV, and other serious conditions with high unmet need.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2026
Oct 2024
Jan 2016
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
